NO963113L - Farmasöytiske preparater omfattende hirudin - Google Patents

Farmasöytiske preparater omfattende hirudin

Info

Publication number
NO963113L
NO963113L NO963113A NO963113A NO963113L NO 963113 L NO963113 L NO 963113L NO 963113 A NO963113 A NO 963113A NO 963113 A NO963113 A NO 963113A NO 963113 L NO963113 L NO 963113L
Authority
NO
Norway
Prior art keywords
hirudin
pharmaceutical preparations
freeze
sugar
pharmaceutical composition
Prior art date
Application number
NO963113A
Other languages
English (en)
Norwegian (no)
Other versions
NO963113D0 (no
Inventor
Tudor Arvinte
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO963113D0 publication Critical patent/NO963113D0/no
Publication of NO963113L publication Critical patent/NO963113L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A61K38/58—Protease inhibitors from animals; from humans from leeches, e.g. hirudin, eglin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
NO963113A 1994-01-26 1996-07-25 Farmasöytiske preparater omfattende hirudin NO963113L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9401447A GB9401447D0 (en) 1994-01-26 1994-01-26 Pharmaceutical compositions
PCT/IB1995/000053 WO1995020399A1 (en) 1994-01-26 1995-01-25 Pharmaceutical compositions comprising hirudin

Publications (2)

Publication Number Publication Date
NO963113D0 NO963113D0 (no) 1996-07-25
NO963113L true NO963113L (no) 1996-09-17

Family

ID=10749331

Family Applications (1)

Application Number Title Priority Date Filing Date
NO963113A NO963113L (no) 1994-01-26 1996-07-25 Farmasöytiske preparater omfattende hirudin

Country Status (20)

Country Link
US (1) US6436901B1 (de)
EP (1) EP0758905B1 (de)
JP (2) JP3260760B2 (de)
AT (1) ATE201996T1 (de)
AU (1) AU1391595A (de)
CA (1) CA2181907A1 (de)
DE (1) DE69521315T2 (de)
DK (1) DK0758905T3 (de)
ES (1) ES2159621T3 (de)
FI (1) FI962979L (de)
GB (1) GB9401447D0 (de)
GR (1) GR3036574T3 (de)
HU (1) HU214823B (de)
IL (1) IL112388A0 (de)
MX (1) MX9603010A (de)
NO (1) NO963113L (de)
NZ (1) NZ278433A (de)
PT (1) PT758905E (de)
WO (1) WO1995020399A1 (de)
ZA (1) ZA95577B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6267958B1 (en) 1995-07-27 2001-07-31 Genentech, Inc. Protein formulation
DE19607239A1 (de) 1996-02-27 1997-08-28 Behringwerke Ag Pharmazeutische Zusammensetzung, enthaltend Hirudin und Verfahren zu deren Herstellung
DE59804785D1 (de) 1997-11-22 2002-08-22 Roche Diagnostics Gmbh Verbessertes Verfahren zur Stabilisierung von Proteinen
US6653062B1 (en) * 2000-07-26 2003-11-25 Wisconsin Alumni Research Foundation Preservation and storage medium for biological materials
CA2433936A1 (en) * 2001-01-23 2002-08-22 Boston Scientific Corporation Localized myocardial injection method for treating ischemic myocardium
US7795205B2 (en) * 2004-04-12 2010-09-14 Canyon Pharmaceuticals, Inc. Methods for effecting regression of tumor mass and size in a metastasized pancreatic tumor
KR101188691B1 (ko) 2004-10-29 2012-10-09 파르마 마르 에스.에이. 엑티나시딘 및 디사카라이드를 포함하는 제제

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3342139A1 (de) * 1983-11-22 1985-05-30 Ciba-Geigy Ag, Basel Desulfatohirudine, verfahren zu ihrer herstellung und pharmazeutische mittel
DE3586333T2 (de) 1984-03-27 1992-12-10 Transgene Sa Expressionsvektoren fuer hirudin, transformierte zellen und verfahren zur herstellung von hirudin.
DE3438296A1 (de) 1984-04-18 1985-11-07 Hoechst Ag, 6230 Frankfurt Neue polypeptide mit blutgerinnungshemmender wirkung, verfahren zu deren herstellung bzw. gewinnung, deren verwendung und diese enthaltende mittel
DE3445532A1 (de) 1984-12-13 1986-06-19 Plantorgan Werk Heinrich G.E. Christensen, KG, 2903 Bad Zwischenahn Hirudin-pa, desulfatohirudine-pa, verfahren zur herstellung und pharmazeutische mittel, die diese wirkstoffe enthalten
DE3804600A1 (de) 1988-02-13 1989-08-24 Basf Ag Mischung aus einer thrombolytisch wirkenden und einer antithrombotischen substanz
GB8817161D0 (en) * 1988-07-19 1988-08-24 Ciba Geigy Ag Modified proteins
IT1243358B (it) 1990-07-23 1994-06-10 Iketon Farmaceutici Srl Composizioni farmaceutiche per la somministrazione orale di irudina
AU659432B2 (en) 1991-03-08 1995-05-18 Novartis Ag A method for the inhibition or prevention of tumor cell metastasis with hirudin
GB9303275D0 (en) 1993-02-18 1993-04-07 Ciba Geigy Ag Pharmaceutical compositions
GB9401448D0 (en) 1994-01-26 1994-03-23 Ciba Geigy Ag Stable dry powders

Also Published As

Publication number Publication date
HUT74879A (en) 1997-02-28
DK0758905T3 (da) 2001-09-03
DE69521315T2 (de) 2001-10-31
MX9603010A (es) 1998-01-31
HU9602037D0 (en) 1996-09-30
EP0758905B1 (de) 2001-06-13
HU214823B (hu) 1998-06-29
FI962979A0 (fi) 1996-07-26
AU1391595A (en) 1995-08-15
JP2001026548A (ja) 2001-01-30
ATE201996T1 (de) 2001-06-15
GB9401447D0 (en) 1994-03-23
FI962979A7 (fi) 1996-07-26
NO963113D0 (no) 1996-07-25
WO1995020399A1 (en) 1995-08-03
DE69521315D1 (de) 2001-07-19
NZ278433A (en) 1997-03-24
JPH09508377A (ja) 1997-08-26
IL112388A0 (en) 1995-03-30
JP3260760B2 (ja) 2002-02-25
US6436901B1 (en) 2002-08-20
PT758905E (pt) 2001-11-30
FI962979L (fi) 1996-07-26
CA2181907A1 (en) 1995-08-03
GR3036574T3 (en) 2001-12-31
EP0758905A1 (de) 1997-02-26
ZA95577B (en) 1995-07-26
ES2159621T3 (es) 2001-10-16

Similar Documents

Publication Publication Date Title
FI853913A0 (fi) Farmaceutiska foereningar som antracyklinglykosider.
NL300249I1 (nl) Cefalosporinen en homologen, bereidingen en farmaceutische preparaten.
IL127918A0 (en) Novel amino sugar and related sugar derivatives of indolylopyrrolocarbazoles their use as antitumor agents and pharmaceutical formulations
FI890225L (fi) Dataoeverfoeringssystem, som baer fjaerrstyrningar.
FI944770A7 (fi) Neurotensiiniin vaikuttavia substituoituja 1-naftyylipyratsoli-3-karboksiamideja, niiden valmistus ja niitä sisältäviä farmaseuttisia koostumuksia
FI891865L (fi) Laekemedel som innehaoller azelastin med kontrollerad frigoering av det verksamma aemnet.
NO963113L (no) Farmasöytiske preparater omfattende hirudin
FI972988A0 (fi) Menetelmiä ja farmaseuttisia koostumuksia, joissa käytetään desmetyyliselegiliiniä
NO960272D0 (no) Oksatiolaner, fremgangsmåte for deres fremstilling og farmasöytiske preparater som inneholder de samme
FI894650A0 (fi) Antigen, som associerar till en human tumoer.
TR199501082A2 (tr) Farmasötik formülasyonlar.
FI884545A0 (fi) Farmaceutisk komposition, som innehaoller avsvaellande piperidinoalkanolfoereningar.
ATE28188T1 (de) Antikonvulsive mittel.
DE69023975D1 (de) Tandem-montierte, stirnseitige Dichtungen.
NO890096D0 (no) Pyrazol- og indozolpyridinaminer, en fremgangsmaate for fremstilling og anvendelse derav som medikamenter.
FI910470A0 (fi) Regel.
AU580890B2 (en) P-acylaminobenzamides
FI894072L (fi) Polypeptider anvaendbara som vaccin.
TR25921A (tr) PESTISID ETKINLIGI HAIZ PESTISID ÖZELLIKTE BISIKLOOKTANLAR,BUNLARI IHTIVA EDEN FORMüLASYONLAR VE HAZIRLANMALARINA MAHSUS USULLER.
NO901758D0 (no) Reninhemmende dipeptider, fremgangsmaate for deres fremstilling, midler som inneholder disse og deres anvendelse.
NO903967L (no) Dihydrocaffeinsyrederivater og farmasoeytiske preparater som inneholder disse.
EE04093B1 (et) HIV proteaasi inhibiitorit VX 478 ja vees lahustuva vitamiin E derivaati vitamiin E-TPGSi sisaldavad preparaadid
NO903725L (no) Tilberedning som inneholder natriumnitritt og heksametylentetraamin til groentforensilering.
IT8820572A0 (it) Agente antitussivo e mucoregolatore, sua preparazione e composizioni farmaceutiche.
ITFI930007A0 (it) Tiodiazepine, loro processidi preparazione e composizioni farmaceuti- che che le contengono.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application